TrialJournal for immunotherapy of cancer2025

Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study.

Peter Hillemanns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.